DAVID RUSSELL

BRISTOL, TN NPI 1801845862

General Payments — all program years on this page

$1,750.92

  • Category: General Payments
  • Program years: PY2018–2023
  • Record count: 104
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $389.37 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $389.3721

By paying entity

Latest program year (PY2023) · sorted by reported total.

Paying entityAmountRecords
Astellas Pharma US Inc $113.945
PFIZER INC. $66.714
Avion Pharmaceuticals $64.244
ABBVIE INC. $58.413
MAYNE PHARMA COMMERCIAL LLC $50.333
Novo Nordisk AS $35.742

By program year

Program yearAmountRecords
2018 $131.329
2019 $166.7611
2020 $182.2511
2021 $256.7615
2022 $624.4637
2023 $389.3721

Records — PY2023 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1005923411 Novo Nordisk Inc $14.43 03/13/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1005923417 Novo Nordisk Inc $21.31 07/20/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1032966663 Avion Pharmaceuticals $15.00 02/27/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1032966671 Avion Pharmaceuticals $17.30 01/11/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1032966683 Avion Pharmaceuticals $19.08 04/10/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1032966691 Avion Pharmaceuticals $12.86 06/08/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1033933137 Astellas Pharma US Inc $23.03 03/02/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1034037993 Astellas Pharma US Inc $28.80 04/07/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1034136025 Astellas Pharma US Inc $23.02 06/05/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1034261375 Astellas Pharma US Inc $21.38 07/11/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1034470421 Astellas Pharma US Inc $17.71 09/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049114537 PFIZER INC. $14.75 01/19/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049744913 PFIZER INC. $21.56 02/13/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049744919 PFIZER INC. $16.13 02/23/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049744924 PFIZER INC. $14.27 03/16/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1060860521 MAYNE PHARMA COMMERCIAL LLC $21.16 06/22/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1060860523 MAYNE PHARMA COMMERCIAL LLC $12.73 01/24/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1060860525 MAYNE PHARMA COMMERCIAL LLC $16.44 04/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
998739519 AbbVie Inc. $18.56 03/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
998739525 AbbVie Inc. $17.42 07/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
998739531 AbbVie Inc. $22.43 07/24/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.